Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals appoints Roby Zomer as CEO

Roby Zomer is one of the founders of MGC Pharmaceuticals.
MGC Pharmaceuticals appoints Roby Zomer as CEO
MGC is focused on medical cannabis

MGC Pharmaceuticals (ASX:MXC) founders were key figures in the Israeli medical cannabis industry.

Roby Zomer is one of these founders, and he has now been promoted to chief executive officer.

Zomer has a proven track record of international success within the biotech and agritech sectors.

Key tasks for Zomer will include being responsible for global operations.

The company recently signed a binding Memorandum of Understanding with the Royal Melbourne Institute of Technology.

The agreement is to collaborate on a research initiative to determine and develop the ideal strains of medicinal cannabis in Australia for the treatment of many diseases and conditions.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MXC profile View Profile

MGC Pharmaceuticals Ltd Timeline

Related Articles

medical cannabis concept
February 11 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
Sydney Harbour Bridge
January 23 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.
November 03 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use